TSX Penny Stocks Spotlight: Mundoro Capital And Two Others To Consider

The Canadian market has recently experienced fluctuations due to rising long-term bond yields, which have influenced investor sentiment and led to a temporary dip in stock prices. Despite these challenges, there are still opportunities for investors who can identify stocks with strong financial health and growth potential. Penny stocks, though an older term, remain relevant as they often represent smaller or newer companies that can offer significant value when backed by solid fundamentals.

Underneath we present a selection of stocks filtered out by our screen.

Mundoro Capital (TSXV:MUN)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Mundoro Capital Inc. is involved in the acquisition, exploration, and development of base and precious metal properties in Serbia, Bulgaria, and the United States with a market cap of CA$39.95 million.

Operations: Mundoro Capital Inc. does not report specific revenue segments, focusing instead on the acquisition, exploration, and development of base and precious metal properties across Serbia, Bulgaria, and the United States.

Market Cap: CA$39.95M

Mundoro Capital, with a market cap of CA$39.95 million, remains pre-revenue as it focuses on exploration activities in Serbia, Bulgaria, and the U.S. Recent developments include a 1,288.1-meter diamond drill program at the Skorusa East target within Serbia's Central Timok project under an option earn-in agreement with BHP. Despite being debt-free and having sufficient cash runway for over three years, Mundoro has faced significant insider selling recently and reported a net loss of CA$0.11 million for Q1 2026 compared to a small profit last year. The company's board is experienced with an average tenure of 4.8 years.

• Dive into the specifics of Mundoro Capital here with our thorough balance sheet health report.
• Review our historical performance report to gain insights into Mundoro Capital's track record.

Nova Leap Health (TSXV:NLH)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Nova Leap Health Corp. operates in the United States and Canada, offering home-based and community-based healthcare services, with a market cap of CA$48.90 million.

Operations: The company generates revenue from its operations in Canada, contributing $8.13 million, and the United States, with $25.47 million in revenue.

Market Cap: CA$48.9M

Nova Leap Health Corp., with a market cap of CA$48.90 million, has shown significant financial improvement, reporting a net income of US$0.65 million for Q2 2026 compared to a loss the previous year. The company's earnings growth over the past year is substantial, outpacing industry averages by a large margin. While its short-term liabilities exceed its assets, Nova Leap's debt levels remain satisfactory and well-covered by operating cash flow. Despite high share price volatility and low return on equity at 6.9%, the company benefits from experienced board leadership and stable profit margins over time.

• Navigate through the intricacies of Nova Leap Health with our comprehensive balance sheet health report here.
• Explore historical data to track Nova Leap Health's performance over time in our past results report.

Questor Technology (TSXV:QST)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Questor Technology Inc. is an environmental emissions reduction technology company that designs, manufactures, and services clean combustion systems in Canada and the United States, with a market cap of CA$10.55 million.

Operations: Questor Technology generates revenue primarily through equipment sales and rentals, totaling CA$4.94 million.

Market Cap: CA$10.55M

Questor Technology Inc., with a market cap of CA$10.55 million, operates in the emissions reduction sector and is currently unprofitable, trading significantly below its estimated fair value. Despite having no debt and covering short-term liabilities with assets worth CA$5.8 million, the company faces challenges like high share price volatility and a negative return on equity of -10.6%. Recent investor activism highlights governance issues, with calls for board restructuring to protect shareholder value amid strategic opportunities in international markets. The appointment of Craig Joyce aims to boost revenue growth through strengthened North American market presence.

• Take a closer look at Questor Technology's potential here in our financial health report.
• Gain insights into Questor Technology's future direction by reviewing our growth report.

Turning Ideas Into Actions

• Click through to start exploring the rest of the 328 TSX Penny Stocks now.
• Searching for a Fresh Perspective? Uncover 21 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com